New shot could tame tough eczema
NCT ID NCT07321951
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study tests an experimental injection called SHR-1819 in 200 adults with moderate-to-severe atopic dermatitis (a type of eczema). The goal is to see if it safely reduces skin redness, swelling, and itching. Participants will receive either the drug or a placebo, and their progress will be tracked for several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dermatology Hospital of Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510091, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Hangzhou Third People's Hospital
RECRUITINGHangzhou, Zhejiang, 310009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.